PSIL News and Press, AdvisorShares Psychedelics ETF From 08/24/22

AdvisorShares Expands Cannabis ETF Offerings, Launches MSOS 2x Daily ETF (Ticker: MSOX) PR Newswire Designed for sophisticated investors, MSOX seeks investment returns two-times the daily performance of the AdvisorShares Pure US Cannabis ETF (Ticker: MSOS) ...

On July 13, 2022, two amendments passed in the House of Representatives that would provide psychedelic drug treatment to veterans and active duty service members. A documentary based on Michael Pollan's 2018 book, "How to Change Your Mind," is one of Netflix's most-watched shows. ...

Renewed interest in psychedelics in both public and scientific spaces has increased investor interest in psychedelic stocks. The psychedelic market is projected to achieve a valuation of $10.7 billion by 2027 , and investors are looking to cash in on the industry before it is satura...

This year hasn't been easy for MindMed (NASDAQ:MNMD), which has faced its shares of struggles and is down 46% year to date. A week ago, the FDA placed a clinical hold on its IND submission necessary to begin a phase 2b trial of LSD for generalized anxiety disorder. On the positive s...

The B.A.D. ETF (BAD) has been launched by The Bad Investment Company today on the New York Stock Exchange. BAD is an ETF that provides exposure to investors around U.S. listed companies involved in B.A.D. market segments such as betting, alcohol, cannabis, and drugs (pharmaceuticals...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Psychedelic drugs could be a major game-changer when it comes to treating mental illness, so loading up on some psychedelic stocks only makes sense. All as psilocybin, LSD, MDMA, and mescaline for example show progress in...

NetworkNewsWire Editorial Coverage : Global destigmatization, changing regulations and an upswing in research are speaking loudly to the opportunity for psychedelics to provide tangible improvements in medicine to address some of the most resistant, devastating and expensive conditions know...

KCSA Psychedelics Virtual Investor Conference Presentations Available for On-Demand Viewing Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view presentations PR Newswire NEW YORK , Oct. 18, ...

CHICAGO and TORONTO, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF) , an emerging data driven life sciences company focused on developing innovative approaches for better understanding, ...

TORONTO, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company") , a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurologi...